Quarterly report pursuant to Section 13 or 15(d)

Note 7 - Stockholders' Deficit - Stock Options (Details)

v3.10.0.1
Note 7 - Stockholders' Deficit - Stock Options (Details) - USD ($)
9 Months Ended 12 Months Ended
Sep. 30, 2018
Dec. 31, 2017
Outstanding, Number of Shares (in shares) 15,000  
Outstanding, Weighted Average Exercise Price (in dollars per share) $ 0.13  
Outstanding, Weighted Average Remaining Life (Year) 9 years 251 days 9 years 273 days
Granted, Number of Shares (in shares) 2,220,000  
Granted, Weighted Average Exercise Price (in dollars per share) $ 1.75  
Exercised, Number of Shares (in shares)  
Exercised, Weighted Average Exercise Price (in dollars per share)  
Canceled, Number of Shares (in shares)  
Canceled, Weighted Average Exercise Price (in dollars per share)  
Outstanding, Number of Shares (in shares) 2,235,000 15,000
Outstanding, Weighted Average Exercise Price (in dollars per share) $ 1.74 $ 0.13
Outstanding, Aggregate Intrinsic Value $ 23,100  
Exercisable, Number of Shares (in shares) 3,750  
Exercisable, Weighted Average Exercise Price (in dollars per share) $ 0.13  
Exercisable, Weighted Average Remaining Life (Year) 9 years 3 days  
Exercisable, Aggregate Intrinsic Value $ 5,775